NovaRad unveils new product for orthopedic surgeons

TriMed Staff | | Health Imaging | Screening
PACS and RIS developer, NovaRad Corp. and Orthocrat Ltd. jointly offer a new surgical planning tool to be used in orthopedics.

NovaRad will now distribute Orthocrat's TraumaCad preoperative planning software bundled with NovaPACS to orthopedic clinics throughout the United States. The bundled product will be marketed as OrthoPACS.

Designed specifically for orthopedic surgeons, the Orthocrat TraumaCad/NovaPACS product integrates Ortho tools with a NovaPACS workstation. In addition, the software offers procedure simulation capabilities for fracture reduction, osteotomy, and trauma.

NovaRad has completed its first installation of OrthoPACS at Orthopaedic Trauma and Reconstructive Associates in Peabody, Mass.

TriMed Staff

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.